Informações:
Falhas:
ID
25951
Descrição
Investigators Statement Ropinirole Case Report Form GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Palavras-chave
Versões (1)
- 01/10/2017 01/10/2017 -
Titular dos direitos
gsk
Transferido a
1 de outubro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Similar models
Investigators Statement Ropinirole Case Report Form GSK RRL100013
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
INVESTIGATOR’S STATEMENT
C1710187 (UMLS CUI-1)
C2826892 (UMLS CUI-2)
C2826892 (UMLS CUI-2)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Adverse Event
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1])
completion
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C0805732 (UMLS CUI [1])
laboratory results
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
consent
Item
I certify to the best of my knowledge, that the observations and findings are recorded correctly and completely in this CRF.
boolean
C1511481 (UMLS CUI [1])
Investigator
Item
Investigator
text
C2826892 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])
Sem comentários